Primary Objective
To establish a longitudinal cohort integrating bone marrow imaging with clinical and treatment-related data.
Primary Endpoint
Successful enrollment of eligible participants and collection of relevant imaging and clinical data.
Secondary Objective
* Characterize bone marrow imaging findings across relevant patient populations.
* Evaluate relationships between imaging findings, treatment exposures, hematologic recovery, treatment-related toxicities, and clinical outcomes.
* Assess longitudinal changes in bone marrow imaging findings over time and following cancer therapy.
* Explore associations between imaging findings and laboratory, pathology, and research biomarker data when available.